Akebia Therapeutics (AKBA) Amortizatization of Intangibles (2016 - 2024)
Akebia Therapeutics has reported Amortizatization of Intangibles over the past 9 years, most recently at $9.0 million for Q4 2024.
- Quarterly Amortizatization of Intangibles fell 0.82% to $9.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Sep 2025, down 75.12% year-over-year, with the annual reading at $36.0 million for FY2024, 0.12% changed from the prior year.
- Amortizatization of Intangibles was $9.0 million for Q4 2024 at Akebia Therapeutics, roughly flat from $9.0 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $9.1 million in Q1 2020 and troughed at -$24.3 million in Q4 2020.
- The 5-year median for Amortizatization of Intangibles is $9.0 million (2021), against an average of $7.2 million.
- The largest YoY upside for Amortizatization of Intangibles was 1807.76% in 2020 against a maximum downside of 168.13% in 2020.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$24.3 million in 2020, then soared by 137.14% to $9.0 million in 2021, then increased by 0.36% to $9.0 million in 2022, then fell by 0.01% to $9.0 million in 2023, then dropped by 0.82% to $9.0 million in 2024.
- Per Business Quant, the three most recent readings for AKBA's Amortizatization of Intangibles are $9.0 million (Q4 2024), $9.0 million (Q3 2024), and $9.0 million (Q2 2024).